national institutes health academic centers companies developing asked group evaluate team boston children not group testing adjuvants week example dynavax technologies biopharmaceutical vaccine developer emeryville California clover biopharmaceuticals china based biotechnology company entered research collaboration study vaccine adjuvant combination covid-19 clover developing protein based coronavirus vaccine candidate called covid-19 s trimer dynavax providing technical expertise company adjuvant cpg 1018 according joint companies levy dowling project planning stage aim test vast number possible vaccine adjuvant pairings cells older adults plan find promising candidate combinations moving mouse testing generally important federal approval variables involved host cell proteins target adjuvants use way vaccine